Omnicell (OMCL)
News
Profile
Exchange: NASDAQGM Sector: Technology Industry: Computer Based Systems
Omnicell, Inc., is a leading provider of solutions targeting patient safety and operational efficiency in healthcare facilities. Its healthcare automation solutions are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies, and are intended to enhance patient safety, reduce medication errors, improve workflow and increase operational efficiency. When used in combination, the company's products and services provide healthcare facilities with a comprehensive solution designed to enhance patient safety and improve operational efficiency and also achieve automation of medication and supply management from the arrival at the loading dock to the patient's bedside. It also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, California.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Omnicell is down 9.62% over the last year vs S&P 500 Total Return up 2.03%, XATA Corporation down 48.96%, and RadiSys Corporation down 30.39%.
- OMCL Total Returns
- ^SPXTR Total Returns
- XATA Total Returns
- RSYS Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these OMCL related companies
Pro Strategies Featuring OMCL
Did Omnicell make it into our Pro Portfolio Strategies?
OMCL Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other OMCL Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OMCL | 13.71 | -0.06 | -0.44% | 459.15M |
| OMC | 49.78 | -0.32 | -0.64% | 13.58B |
| OLP | 18.56 | -0.26 | -1.38% | 273.39M |
| OLCB | 1.10 | +0.09 | +8.91% | 21.69M |
| OIB | 7.81 | +0.03 | +0.45% | |
| OFG | 10.79 | +0.00 | +0.00% | 441.31M |
| OESX | 2.02 | +0.01 | +0.50% | 46.48M |
| OEH | 8.20 | -0.10 | -1.20% | 842.06M |
| OCN | 15.87 | -0.03 | -0.19% | 2.064B |
| OCFC | 14.35 | +0.13 | +0.91% | 266.48M |
